Lineage Cell Therapeutics
LCTX
LCTX
68 hedge funds and large institutions have $134M invested in Lineage Cell Therapeutics in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 74 → 68 (-6)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
82% less call options, than puts
Call options by funds: $284K | Put options by funds: $1.55M
Holders
68
Holding in Top 10
1
Calls
$284K
Puts
$1.55M
Top Buyers
| 1 | +$6.06M | |
| 2 | +$561K | |
| 3 | +$560K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$343K |
| 5 |
State Street
Boston,
Massachusetts
|
+$259K |
Top Sellers
| 1 | -$1.62M | |
| 2 | -$376K | |
| 3 | -$155K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$147K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$102K |